Related Experiment Video
Updated: Jul 19, 2026

Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins
Published on: July 1, 2011
Identification of protective components of two major outer membrane proteins of spotted fever group Rickettsiae
C M Díaz-Montero1, H M Feng, P A Crocquet-Valdes
1Department of Pathology and World Health Organization Collaborating Center for Tropical Diseases, University of Texas Medical Branch, Galveston 77555-0609, USA.
Abstract:
Fragments representing the genes of the two major outer membrane proteins of spotted fever group rickettsiae (rOmpA and rOmpB) were tested as DNA vaccines. Immunizations with each of three fragments (rompA4999-6710, rompB1550-2738, and rompB2459-4123) conferred a degree of protection on vaccinated mice against virulent rickettsial challenge. Protection was achieved when DNA immunizations were followed by booster immunizations with the homologous recombinant protein. Proliferation and gamma-interferon secretion were detected after in vitro stimulation of lymphocytes from immunized animals with whole Rickettsia conorii antigen. The data validate particular segments of rOmpA and rOmpB as potent immunogens and hence as sources of immunostimulatory elements with specificity for T lymphocytes, which are the key effectors of protective immunity against rickettsial infections.
Insights
DNA vaccines using outer membrane protein fragments (rOmpA and rOmpB) from spotted fever rickettsiae offer protection in mice. Boosters with recombinant proteins enhance this immunity, highlighting T lymphocyte responses.
Area of Science:
- Microbiology
- Immunology
- Vaccine Development
Background:
- Spotted fever group rickettsiae are significant human pathogens.
- Outer membrane proteins (OMPs) like rOmpA and rOmpB are key targets for immune responses.
- Developing effective vaccines against rickettsial infections remains a priority.
Purpose of the Study:
- To evaluate the immunogenicity and protective efficacy of DNA vaccine fragments encoding rOmpA and rOmpB.
- To assess the role of T lymphocytes in the immune response induced by these DNA vaccines.
- To identify specific protein segments that can serve as potent immunogens.
Main Methods:
- Gene fragments of rOmpA and rOmpB were cloned into DNA vaccine constructs.
- Mice were immunized with DNA vaccines and subsequently challenged with virulent rickettsiae.
- Some groups received booster immunizations with homologous recombinant proteins.
- Lymphocyte proliferation and gamma-interferon secretion were measured upon in vitro stimulation.
Main Results:
- DNA immunization with specific rOmpA and rOmpB fragments conferred partial protection against rickettsial challenge.
- Complete protection was achieved when DNA vaccination was followed by recombinant protein boosters.
- Immune responses included lymphocyte proliferation and gamma-interferon secretion, indicating T lymphocyte activation.
Conclusions:
- Specific segments of rOmpA and rOmpB are potent immunogens capable of inducing protective immunity.
- These protein fragments can stimulate T lymphocytes, which are crucial for rickettsial infection control.
- The findings support the development of subunit vaccines targeting these outer membrane proteins.
More Related Videos
Related Concept Videos
Intracellular Movement of Viruses and Bacteria
Formation of Lipopolysaccharides
Rapid Identification of Pathogens
Rocky Mountain Spotted Fever
Plague

